Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations

By Lee Soohyeon  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 809-817

Springer Publishing Company

Access to resources Recommend Favorite

Leptomeningeal metastases from solid malignancy: a review

By Taillibert Sophie   Laigle-Donadey Florence   Chodkiewicz Catherine   Sanson Marc   Hoang-Xuan Khê   Delattre Jean-Yves  

Journal of Neuro-Oncology, Vol. 75, Iss. 1, 2005-10 ,pp. : 85-99

Springer Publishing Company

Access to resources Recommend Favorite

Integrins and Prostate Cancer Metastases

By Fornaro M.   Manes T.   Languino L.R.  

Cancer and Metastasis Reviews, Vol. 20, Iss. 3-4, 2001-12 ,pp. : 321-331

Springer Publishing Company

Access to resources Recommend Favorite

High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer

By Clarke Jennifer   Pao William   Wu Nian   Miller Vincent   Lassman Andrew  

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 283-286

Springer Publishing Company

Access to resources Recommend Favorite

CSF CA 15-3 in breast cancer-related leptomeningeal metastases

By Le Rhun Emilie   Kramar Andrew   Salingue Sophie   Girot Marie   Rodrigues Isabelle   Mailliez Audrey   Zairi Fahed   Bakhache Edgar   Robin Yves   Taillibert Sophie   Dubois François   Bonneterre Jacques   Chamberlain Marc  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 117-124

Springer Publishing Company

Access to resources Recommend Favorite